Alpha Teknova (TKNO) Accumulated Expenses (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Accumulated Expenses came in at $3.4 million in Q1 2026, down 7.61% year-on-year from $3.6 million in Q1 2025, and down 21.48% on a QoQ basis from $4.3 million in Q4 2025.
Alpha Teknova (TKNO) Accumulated Expenses (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Accumulated Expenses data on file, last reported at $3.4 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 7.61% year-over-year to $3.4 million in Q1 2026; TTM through Mar 2026 was $3.4 million, a 7.61% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, up 40.84% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.4 million, down from $4.3 million in the prior quarter.
- Over the last five years, Accumulated Expenses for TKNO reached as high as $8.2 million in Q2 2022 and fell as low as $2.1 million in Q2 2024.
- Historically, Accumulated Expenses has averaged $4.0 million across 5 years, with a median of $3.6 million in 2025.
- Across the five-year window, Accumulated Expenses jumped 340.47% in 2022 and slumped 55.66% in 2023, its largest moves.
- Year by year, Accumulated Expenses stood at $2.8 million in 2022, then soared by 99.54% to $5.6 million in 2023, then tumbled by 45.49% to $3.0 million in 2024, then surged by 40.84% to $4.3 million in 2025, then dropped by 21.48% to $3.4 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $3.4 million in Q1 2026, $4.3 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.36 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.97 Mn |
| Jun 30, 2025 | 3.39 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 4.37 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 3.57 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 5.15 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 6.59 Mn |
| Jun 30, 2022 | 8.25 Mn |
| Mar 31, 2022 | 2.27 Mn |
| Dec 31, 2021 | 5.58 Mn |
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | 1.87 Mn |